Effects of α-Lipoic Acid, Carnosine, and Thiamine Supplementation in Obese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study

논문상세정보

' Effects of α-Lipoic Acid, Carnosine, and Thiamine Supplementation in Obese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study' 의 참고문헌

  • Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
    Stirban A [2014]
  • Use of carnosine for oxidative stress reduction in different pathologies
  • Thiamine deficiency in diabetes mellitus and the impact of thiamine replacement on glucose metabolism and vascular disease
    Page GL [2011]
  • The potential role of thiamine (vitamin B1) in diabetic complications
  • The impact of thiamine treatment in the diabetes mellitus
    Luong KV [2012]
  • The impact of thiamine supplementation on blood pressure, serum lipids and Creactive protein in individuals with hyperglycemia: A randomized, double-blind cross-over trial
  • The effects of lipoic acid and a-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: A randomized, double-blind, placebocontrolled trial
  • The Maillard reaction in the human body. The main discoveries and factors that affect glycation
    Tessier FJ [2010]
  • Relationship between diabetes and mortality. A population study using record linkage
    Morgan CL [2000]
  • Reduced muscle carnosine content in type 2, but not in type 1 diabetic patients
    Gualano B [2012]
  • Prevention of protein glycation by natural compounds
  • Platelet inhibition by insulin is absent in type 2 diabetes mellitus
    Ferreira IA [2006]
  • Platelet dysfunction in type 2 diabetes
    Vinik AI [2001]
  • Oxidative stress and platelets
    Freedman JE [2008]
  • Overview of platelet physiology:Its hemostatic and nonhemostatic role in disease pathogenesis
    Ghoshal K [2014]
  • Obesity and cardiovascular disease:friend or foe?
    Kim SH [2016]
  • Mortality during 25 years of follow-up of a cohort with diabetes
    Swerdlow AJ [1996]
  • Metabolic benefits of six-month thiamine supplementation in patients with and without diabetes mellitus type 2
    Al-Attas O [2014]
  • Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats
    Khamaisi M [1997]
  • Kinetics of the sulphite-inhibited Maillard reaction: The effect of sulphite ion
    Wedzicha BL [1988]
  • Is epinephrine-induced platelet aggregation autoregulated by its metabolic degradation products in vivo?
  • Interplay between oxidative stress and metabolism in signalling and disease
    Kelley EE [2017]
  • Inhibitory effect of a-lipoic acid on platelet aggregation is mediated by PPARs
    Chou TC [2011]
  • Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile andmitochondrial functions
    Neviere R [2016]
  • Hyperglycemiainduced oxidative stress and its role in diabetes mellitus related cardiovascular diseases
  • High-dose thiamine therapy counters dyslipidaemia in streptozotocininduced diabetic rats
  • High-dose thiamine supplementation improves glucose tolerance in hyperglycaemic individuals: A randomized, double-blind crossover trial
  • Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: A randomized double-blinded placebocontrolled study
  • Engagement of the insulin-sensitive pathway in the stimulation of glucose transporter by alpha-lipoic acid in 3T3-L1 adipocytes
    Yaworsky K [2000]
  • Effects of thiamine deficiency on the secretion of insulin and the metabolismof glucose in isolated rat pancreatic islets
  • Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats
  • Effects of carnosine supplementation on glucose metabolism: Pilot clinical trial
  • Effect of insulin and oligofructose enrichment of the diet on rats suffering thiamine deficiency
    Debski B [2011]
  • Effect of a-lipoic acid on platelet reactivity in type 1 diabetic patients
    Mollo R [2012]
  • Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I
    Paneni F [2013]
  • Diabetes and alpha lipoic Acid
    Golbidi S [2011]
  • Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptides
  • Carnosine: New concept for the function of an old molecule
    Boldyrev AA [2012]
  • Carnosine scavenging of glucolipotoxic free radicals enhances insulin secretion and glucose uptake
    Cripps MJ [2017]
  • Carnosine decreases IGFBP1 production in db/db mice through suppression of HIF-1
    Forsberg EA [2015]
  • Biochemical and clinical relevance of alpha lipoic acid: Antioxidant and antiinflammatory activity, molecular pathways and therapeutic potential
    Tibullo D [2017]
  • Antiplatelet activity of alpha-lipoic acid
    Lai YS [2010]
  • Antioxidant effect of carnosine treatment on renal oxidative stress in streptozotocin-induced diabetic rats
    Yay A [2014]
  • Antioxidant and antiplatelet properties of milk from goat, donkey and cow: An in vitro, ex vivo and in vivo study
    Simos Y [2011]
  • Alpha lipoic acid prevents pancreatic islet cells damage and dyslipidemia in streptozotocin-induced diabetic rats
    Budin SB [2007]
  • Advanced glycation end products: sparking the development of diabetic vascular injury
    Goldin A [2006]
  • Advanced glycation end products, oxidative stress and diabetic nephropathy
    Yamagishi S [2010]
  • Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes
    Basta G [2004]
  • A simple test to monitor oxidative stress
    Cesarone MR [1999]